ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID: NCT06863961

Public ClinicalTrials.gov record NCT06863961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Patients With Moderate to Severe Atopic Dermatitis

Study identification

NCT ID
NCT06863961
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
160 participants

Conditions and interventions

Interventions

  • Afimkibart Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2025
Primary completion
Oct 4, 2026
Completion
Apr 18, 2027
Last update posted
May 5, 2026

2025 – 2027

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
First OC Dermatology Fountain Valley California 92708 Recruiting
The Center for Dermatology Clinical Research Fremont California 94538 Recruiting
University of California Los Angeles Los Angeles California 90024 Recruiting
Dermatology Research Associate Los Angeles California 90045 Recruiting
Suncoast Research Associates LLC - ERN - PPDS Doral Florida 33172 Recruiting
Olympian Clinical Research Tampa Florida 33615 Recruiting
Hamilton Research, LLC Alpharetta Georgia 30022 Recruiting
Dermatology Affiliates Research Institute, LLC Atlanta Georgia 30305 Recruiting
Dawes Fretzin Clinical Res LLC Indianapolis Indiana 46250 Recruiting
Southern Indiana Clinical Trials New Albany Indiana 47150 Recruiting
Revival Research Institute, LLC Troy Michigan 48084 Recruiting
Regents of the University of Minnesota Minneapolis Minnesota 55455 Recruiting
Care Access Research - Hoboken Hoboken New Jersey 07030 Recruiting
Forest Hill Dermatology Group Kew Gardens New York 11415 Recruiting
Weill Cornell Medicine New York New York 10075 Recruiting
Centricity Research Dublin Columbus Ohio 43213 Recruiting
DOCS Clinical Research - Springfield Springfield Ohio 45505 Recruiting
Central Sooner Research Oklahoma City Oklahoma 73170 Recruiting
Oregon Health & Science University Portland Oregon 97239 Recruiting
Best Skin Research LLC Camp Hill Pennsylvania 17011 Recruiting
Goodlettsville Dermatology Research Goodlettsville Tennessee 37072 Withdrawn
Cumberland Skin Center for Clinical Research LLC Hermitage Tennessee 37076 Withdrawn
Arlington Research Center Arlington Texas 76011 Recruiting
Modern Research Associates Dallas Texas 75231 Recruiting
Reveal Research Institute Dallas Texas 75235 Recruiting
Rainey & Finklea Dermatology d/b/a RFSA Dermatology, PLLC San Antonio Texas 78213 Recruiting
Care Access Research - Arlington Arlington Virginia 22206 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06863961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06863961 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →